122 related articles for article (PubMed ID: 26115839)
1. The impact of clinical characteristics on outcomes from maintenance therapy in non-small cell lung cancer: A systematic review with meta-analysis.
Zhou F; Jiang T; Ma W; Gao G; Chen X; Zhou C
Lung Cancer; 2015 Aug; 89(2):203-11. PubMed ID: 26115839
[TBL] [Abstract][Full Text] [Related]
2. Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis.
Behera M; Owonikoko TK; Chen Z; Kono SA; Khuri FR; Belani CP; Ramalingam SS
Lung Cancer; 2012 Aug; 77(2):331-8. PubMed ID: 22546678
[TBL] [Abstract][Full Text] [Related]
3. Overall survival benefits for combining targeted therapy as second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of published data.
Qi WX; Wang Q; Jiang YL; Sun YJ; Tang LN; He AN; Min DL; Lin F; Shen Z; Yao Y
PLoS One; 2013; 8(2):e55637. PubMed ID: 23409011
[TBL] [Abstract][Full Text] [Related]
4. Endpoints in phase II trials for advanced non-small cell lung cancer.
Mandrekar SJ; Qi Y; Hillman SL; Allen Ziegler KL; Reuter NF; Rowland KM; Kuross SA; Marks RS; Schild SE; Adjei AA
J Thorac Oncol; 2010 Jan; 5(1):3-9. PubMed ID: 19884856
[TBL] [Abstract][Full Text] [Related]
5. Combined EGFR and VEGFR versus single EGFR signaling pathways inhibition therapy for NSCLC: a systematic review and meta-analysis.
Zhang X; Li Y; Li H; Qin Y; Bai C; Xu F; Zhu T; Xu J; Wu M; Wang C; Wei L; He J
PLoS One; 2012; 7(8):e40178. PubMed ID: 22916093
[TBL] [Abstract][Full Text] [Related]
6. The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials.
Siddiqui F; Bae K; Langer CJ; Coyne JC; Gamerman V; Komaki R; Choy H; Curran WJ; Watkins-Bruner D; Movsas B
J Thorac Oncol; 2010 May; 5(5):631-9. PubMed ID: 20432520
[TBL] [Abstract][Full Text] [Related]
7. Trends and predictors of Quality of Life in lung cancer survivors.
Bade BC; Zhao J; Li F; Tanoue L; Lazowski H; Alfano CM; Silvestri GA; Irwin ML
Lung Cancer; 2024 May; 191():107793. PubMed ID: 38640687
[TBL] [Abstract][Full Text] [Related]
8. Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.
Li Y; Wong M; Zhan L; Corke L; Brown MC; Cheng S; Khan K; Balatnaram K; Chowdhury M; Sabouhanian A; Herman J; Walia P; Strom E; Patel D; García-Pardo M; Schmid S; Eng L; Sacher AG; Leighl N; Bradbury PA; Shepherd FA; Shultz D; Liu G
Lung Cancer; 2024 Jun; 192():107823. PubMed ID: 38763103
[TBL] [Abstract][Full Text] [Related]
9. Pathological response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis.
Waser NA; Quintana M; Schweikert B; Chaft JE; Berry L; Adam A; Vo L; Penrod JR; Fiore J; Berry DA; Goring S
JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521542
[TBL] [Abstract][Full Text] [Related]
10. Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer.
Fernández-López C; Expósito-Hernández J; Arrebola-Moreno JP; Calleja-Hernández MÁ; Expósito-Ruíz M; Guerrero-Tejada R; Linares I; Cabeza-Barrera J
Cancer Med; 2016 Sep; 5(9):2190-7. PubMed ID: 27449070
[TBL] [Abstract][Full Text] [Related]
11. Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer.
Cramer-van der Welle CM; Peters BJM; Schramel FMNH; Klungel OH; Groen HJM; van de Garde EMW; ;
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30487206
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary meeting review in nonsmall cell lung cancer: a systematic review and meta-analysis.
Stirling RG; Harrison A; Huang J; Lee V; Taverner J; Barnes H
Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38719736
[TBL] [Abstract][Full Text] [Related]
13. Background and clinical significance of biomarker-based patient enrichment in non-small-cell lung cancer drug development.
Harada K; Ono S
Sci Rep; 2024 Mar; 14(1):7194. PubMed ID: 38531888
[TBL] [Abstract][Full Text] [Related]
14. Improving Outcomes in Advanced Lung Cancer: Maintenance therapy in non-small-cell lung carcinoma.
Furrukh M; Burney IA; Kumar S; Zahid KF; Al-Moundhri M
Sultan Qaboos Univ Med J; 2013 Feb; 13(1):3-18. PubMed ID: 23573377
[TBL] [Abstract][Full Text] [Related]
15. Update on the evidence regarding maintenance therapy.
Lee JE; Chung CU
Tuberc Respir Dis (Seoul); 2014 Jan; 76(1):1-7. PubMed ID: 24523811
[TBL] [Abstract][Full Text] [Related]
16. Personalized choice of maintenance therapies in non-small-cell lung cancer.
Blais N; Corrales-Rodriguez L
Curr Oncol; 2012 Jun; 19(Suppl 1):S64-72. PubMed ID: 22787413
[TBL] [Abstract][Full Text] [Related]
17. What is the role of maintenance therapy in the treatment of non-small cell lung cancer?
Jiang Y; Owonikoko TK; Ramalingam SS; Khuri FR; Belani CP
Ther Adv Med Oncol; 2010 Jul; 2(4):229-35. PubMed ID: 21789136
[No Abstract] [Full Text] [Related]
18. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
[TBL] [Abstract][Full Text] [Related]
19. New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches.
Baughman RP; Grutters JC
Lancet Respir Med; 2015 Oct; 3(10):813-22. PubMed ID: 26204816
[TBL] [Abstract][Full Text] [Related]
20. Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia.
Claessens YE; Debray MP; Tubach F; Brun AL; Rammaert B; Hausfater P; Naccache JM; Ray P; Choquet C; Carette MF; Mayaud C; Leport C; Duval X
Am J Respir Crit Care Med; 2015 Oct; 192(8):974-82. PubMed ID: 26168322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
